BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3526423)

  • 1. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases.
    Bernier J; Bataini JP
    Radiother Oncol; 1986 Jun; 6(2):87-103. PubMed ID: 3526423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cervical disease and its definitive radiotherapeutic management on survival: experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx.
    Bataini JP; Bernier J; Jaulerry C; Brunin F; Pontvert D
    Laryngoscope; 1990 Jul; 100(7):716-23. PubMed ID: 2362531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes.
    Bataini JP; Bernier J; Asselain B; Lave C; Jaulerry C; Brunin F; Pontvert D
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):635-42. PubMed ID: 3350718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the oropharynx: an analysis of 213 consecutive patients scheduled for primary radiotherapy.
    Johansen LV; Overgaard J; Overgaard M; Birkler N; Fisker A
    Laryngoscope; 1990 Sep; 100(9):985-90. PubMed ID: 2395408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
    Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy.
    Bataini JP; Bernier J; Jaulerry C; Brunin F; Pontvert D; Lave C
    Int J Radiat Oncol Biol Phys; 1987 Jun; 13(6):817-24. PubMed ID: 3583850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of postradiotherapy neck dissection in supraglottic carcinoma.
    Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
    Maciejewski B; Withers HR; Taylor JM; Hliniak A
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined surgery and postoperative irradiation in the treatment of cervical lymph nodes.
    Goffinet DR; Fee WE; Goode RL
    Arch Otolaryngol; 1984 Nov; 110(11):736-8. PubMed ID: 6487124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.
    Chow E; Payne D; Keane T; Panzarella T; Izard MA
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):149-54. PubMed ID: 9300749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
    Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
    Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
    Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
    Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Split therapy: planned neck dissection followed by definitive radiotherapy for a T1, T2 pharyngolaryngeal primary cancer with operable N2, N3 nodal metastases--a prospective study.
    D'cruz AK; Pantvaidya GH; Agarwal JP; Chaukar DA; Pathak KA; Deshpande MS; Pai PS; Chaturvedi P; Dinshaw KA
    J Surg Oncol; 2006 Jan; 93(1):56-61. PubMed ID: 16353188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of neck node control in radically irradiated squamous cell carcinoma of the oropharynx and laryngopharynx.
    Varghese C; Sankaranarayanan R; Nair B; Nair MK
    Head Neck; 1993; 15(2):105-8. PubMed ID: 8440610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery.
    Levendag P; Braaksma M; Coche E; van Der Est H; Hamoir M; Muller K; Noever I; Nowak P; van Sörensen De Koste J; Grégoire V
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):113-23. PubMed ID: 14697428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.